
Cosciens Biopharma Investor Relations Material
Latest events

AGM 2024
Cosciens Biopharma

Q2 2025
14 Aug, 2025

Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cosciens Biopharma Inc
Access all reports
Cosciens Biopharma Inc is a Chinese biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. The company targets therapeutic areas including oncology, immunology, and central nervous system disorders. It employs proprietary drug discovery platforms and engages in clinical development activities. The company is headquartered in Suzhou, China, and its shares are listed on the SSE STAR Market.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CSCI
Country
🇨🇦 Canada